4D Molecular Therapeutics (FDMT) Insider Trading & Ownership $3.76 -0.06 (-1.44%) As of 03:48 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends 4D Molecular Therapeutics (NASDAQ:FDMT) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage7.30%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)2Amount OfInsider Selling(Last 12 Months)$1.34 M Get FDMT Insider Trade Alerts Want to know when executives and insiders are buying or selling 4D Molecular Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address FDMT Insider Buying and Selling by Quarter Remove Ads 4D Molecular Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails9/16/2024Scott BizilyInsiderSell500$16.33$8,165.00 7/16/2024Scott BizilyInsiderSell1,750$27.11$47,442.50 7/11/2024Scott BizilyInsiderSell1,996$25.00$49,900.00 7/10/2024David KirnCEOSell12,923$22.49$290,638.27 7/1/2024Scott BizilyInsiderSell4,248$21.36$90,737.28 6/24/2024David KirnCEOSell12,930$23.10$298,683.00 5/16/2024Scott BizilyInsiderSell1,750$25.45$44,537.50 4/16/2024Scott BizilyInsiderSell1,750$25.74$45,045.00 4/1/2024Scott BizilyInsiderSell8,153$31.78$259,102.34 3/27/2024Scott BizilyInsiderSell5,833$35.04$204,388.32 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. (Data available from 1/1/2013 forward) FDMT Insider Trading Activity - Frequently Asked Questions Who is on 4D Molecular Therapeutics's Insider Roster? The list of insiders at 4D Molecular Therapeutics includes David Kirn, Global Investors Lp Viking, Jacob Chacko, Robert Young Kim, and Scott Bizily. Learn more on insiders at FDMT. What percentage of 4D Molecular Therapeutics stock is owned by insiders? 7.30% of 4D Molecular Therapeutics stock is owned by insiders. Learn more on FDMT's insider holdings. Which 4D Molecular Therapeutics insiders have been buying company stock? The following insider purchased FDMT shares in the last 24 months: Global Investors Lp Viking ($13,600,000.00). How much insider buying is happening at 4D Molecular Therapeutics? Insiders have purchased a total of 850,000 FDMT shares in the last 24 months for a total of $13,600,000.00 bought. Which 4D Molecular Therapeutics insiders have been selling company stock? The following insiders have sold FDMT shares in the last 24 months: David Kirn ($4,017,438.68), Global Investors Lp Viking ($10,546,200.00), Jacob Chacko ($100,250.00), Robert Young Kim ($737,787.60), and Scott Bizily ($1,275,773.01). How much insider selling is happening at 4D Molecular Therapeutics? Insiders have sold a total of 781,214 4D Molecular Therapeutics shares in the last 24 months for a total of $16,677,449.29 sold. 4D Molecular Therapeutics Key ExecutivesDr. John F. Milligan Ph.D. (Age 63)Executive Chairman Compensation: $150kDr. David H. Kirn M.D. (Age 61)Co-Founder, CEO & Director Compensation: $1.01MDr. Fariborz Kamal Ph.D. (Age 61)President & COO Compensation: $786.2kDr. Noriyuki Kasahara M.D. (Age 61)Ph.D., Chief Scientific Officer Compensation: $201.29kDr. Robert Y. Kim M.B.A. (Age 63)M.D., Chief Medical Officer Compensation: $704.84kMs. Theresa Janke (Age 49)Co-Founder & Chief of Staff Compensation: $652.32kMr. Uneek Mehra (Age 52)Chief Financial & Business Officer Dr. Scott P. Bizily J.D. (Age 51)Ph.D., Chief Legal Officer & Corporate Secretary Dr. An Song Ph.D.Chief Development OfficerDr. Alan H. Cohen FAAAAI (Age 63)FAAP, FACAAI, FCCP, M.D., Senior VP & Therapeutic Area Head of Pulmonology More Insider Trading Tools from MarketBeat Related Companies DNTH Insider Trades MRVI Insider Trades IMNM Insider Trades XERS Insider Trades BCYC Insider Trades ABCL Insider Trades CRMD Insider Trades ORGO Insider Trades QURE Insider Trades NUVB Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Grocery Outlet Insider and Institutional Buyers Signal BottomSentinelOne Insider Selling? Why Investors Should Stay Bullish 3 Companies Buying Back Stock—Why It MattersInsider Scoop: 4 Stocks Insiders Are Buying and Selling2 Stocks Insiders Are Buying and 1 They're Selling This page (NASDAQ:FDMT) was last updated on 3/19/2025 by MarketBeat.com Staff From Our PartnersElon Musk Wants to Audit Fort Knox—What It Means for Your RetirementYou can take advantage of the coming tariff-fueled gold melt-up right inside your IRA or 401(k) – 100% TAX-FRE...Colonial Metals | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 4D Molecular Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share 4D Molecular Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
